Continue to Site

FDA approves Biotronik’s self-expanding stent system

July 26, 2022 By Sean Whooley

Biotronik Pulsar-18 T3 self-expanding stent — The Pulsar-18 T3 self-expanding stent. [Image from Biotronik]

Biotronik announced today that it received FDA approval for its Pulsar-18 T3 peripheral self-expanding stent system.

Pulsar-18 T3 combines a 4-French low-profile delivery system with a tri-axial system with a braided shaft design and thin struts with low chronic outward force (COF), creating an improved implantation procedure for endovascular treatments.

Get the full story at our sister site, MassDevice.

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at swhooley@wtwhmedia.com.